Inflammatory damage markers

Inflammatory damage markers are a broad category of biological substances that indicate the presence and severity of inflammation and subsequent tissue injury (StatPearls, 2023). This diverse group includes acute-phase proteins like C-reactive protein (CRP), pro-inflammatory cytokines such as Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-alpha), and cellular enzymes like Lactate Dehydrogenase (LDH) (NIH, 2022). These markers play a fundamental role in clinical diagnostics by helping to monitor the progression of infections, autoimmune conditions, and cardiovascular diseases. While the collective group is not a singular therapeutic target, individual components within this category, particularly specific cytokines, serve as key targets for modern biological therapies like monoclonal antibodies (Wikipedia, 2024). Clinicians rely on these biomarkers to evaluate therapeutic efficacy and assess patient prognosis, although their lack of specificity often requires interpretation alongside other clinical findings.

Other names

Inflammatory biomarkersMarkers of inflammationAcute phase reactantsPro-inflammatory markersInflammatory damage indicators

Not applicable; this is a collective term for diverse diagnostic biomarkers rather than a specific therapeutic target.